4//SEC Filing
Gayko Urte 4
Accession 0000921895-21-002700
CIK 0001599298other
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 5:17 PM ET
Size
8.1 KB
Accession
0000921895-21-002700
Insider Transaction Report
Form 4
Gayko Urte
Director
Transactions
- Award
Stock Option (right to buy)
2021-11-03+200,000→ 200,000 totalExercise: $5.54Exp: 2031-11-03→ Common Stock (200,000 underlying) - Award
Stock Option (right to buy)
2021-11-03+4,041→ 204,041 totalExercise: $5.54Exp: 2031-11-03→ Common Stock (4,041 underlying)
Footnotes (3)
- [F1]The option was granted on November 3, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 3, 2022.
- [F2]The option was granted on November 3, 2021 and represents a pro rata amount of the annual 25,000 option board grant based approximately on the number of days this year the reporting person is anticipated to serve as a director. The shares underlying the option are scheduled to vest in full on December 31, 2021.
- [F3]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001559217
Filing Metadata
- Form type
- 4
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 5:17 PM ET
- Size
- 8.1 KB